Biodegradable Block Copolymer Nanosystems for Targeted Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biodegradable polymers for drug delivery systems face limitations in targeting a wide variety of drugs with distinct physicochemical attributes, such as solubility and molecular weight, and lack efficient targeted delivery capabilities.
Innovation Solution
A biodegradable polymer system comprising block copolymers with biodegradable polyester blocks and polyethylene glycol (PEG) blocks, designed to form nanosystems with specific biological functions, allowing for optimized ligand-receptor stoichiometry and tunable release properties, enabling precise delivery of bioactive compounds to specific sites in the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If commercially available biodegradable polymers (PLA, PGA, PLGA) are used for drug delivery, then biocompatibility and regulatory compliance are improved, but the ability to deliver drugs with distinct physicochemical attributes and achieve targeted delivery deteriorates
Solution Approach 1:
The patent creates a universal polymer platform with modular architecture that can deliver diverse drugs (peptides, proteins, small molecules) through standardized mechanisms while maintaining biocompatibility. The block copolymer system with PEG and biodegradable polyester blocks provides a multi-functional platform applicable to various drug types and delivery routes
Solution Approach 2:
The patent introduces site-specific functionalization through ligand conjugation to polymer blocks, creating local targeting capabilities while maintaining the overall biocompatible polymer structure. Different ligands can be attached to specific blocks to target different receptors or tissues, allowing localized delivery functions within a universally compatible polymer system
2Adaptability or versatility
If current copolymer-based drug carriers are used, then some targeted delivery is achieved, but efficient receptor-specific targeted delivery and optimized ligand-receptor stoichiometry are not achieved
Solution Approach 1:
The patent segments the polymer into distinct functional blocks (PEG blocks for solubility and biocompatibility, polyester blocks for drug loading and controlled degradation). This segmentation allows independent optimization of each block's properties and enables precise control over ligand-to-receptor ratios by adjusting block composition and length
Solution Approach 2:
The patent systematically varies polymer parameters including block length, molecular weight, ligand density, and composition ratios to optimize ligand-receptor stoichiometry. By changing these parameters, the system achieves precise control over targeting efficiency and receptor saturation, enabling optimized delivery at the molecular level
3Adaptability or versatility
If polymer nanosystems are designed for specific biological functions, then targeted delivery and tunable release properties are improved, but system complexity increases
Solution Approach 1:
The patent divides the complex polymer system into standardized modular blocks with defined functions (solubility, drug loading, targeting, degradation). This modular segmentation simplifies the design process by allowing researchers to assemble complex functionalities from predefined building blocks rather than designing entire systems from scratch
Solution Approach 2:
The patent creates universal polymer blocks that can perform multiple functions or be adapted to different functions through ligand attachment. For example, PEG blocks provide both solubility and serve as attachment points for targeting ligands, reducing the need for separate specialized components and simplifying overall system architecture
Data Source
AI summary
The present invention provides a biodegradable “precision polymer system” (poly system) and methods for preparing pharmaceutically effective “precision polymer nanosystems” (polymer nanosystem) for delivery and/or targeting of drugs or drug like compounds.